Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Biocon Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

29 Oct 2016 Reuters Investment Profile 12 $20.00

Biocon Limited (BIOCON) - Financial and Strategic SWOT Analysis Review

Biocon Limited (BIOCON) - Financial and Strategic SWOT Analysis Review Summary Biocon Limited (Biocon) is a global biopharmac...

02 Nov 2016 GlobalData 114 $300.00

Thomson Reuters Stock Report - Biocon Ltd (BIOCON-IN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

01 Nov 2016 Thomson Reuters Stock Report 11 $25.00

Spark Capital: 2QFY17 Outlook review of Biocon (Rating: REDUCE, TP: Rs.968)

How does our one year outlook change? We downgrade Biocon to REDUCE as the biosimilars opportunity in regulated markets is l...

25 Oct 2016 Spark Capital Advisors(India) Private Limited 6 $46.00

MOSL: BIOCON (Sell)-In-line results-monetization of Biosimilars key catalyst ahead

BIOCON: In-line results; monetization of Biosimilars key catalyst ahead (BIOS IN, Mkt Cap USD3.0b, CMP INR1006, TP INR750, 2...

24 Oct 2016 Motilal Oswal Securities Ltd. 10 $104.00

Is Biocon Ltd Worth a Higher Bid?

24 Oct 2016 Sadif Analytics Prime 12 $25.00

Biocon Ltd. (BIOS) - Qtr. Update - Dated - October 21, 2016

Biocon (Bloomberg: BIOS IN, HOLD, TP – Rs 960, -2% downside from CMP of Rs 980) Q2FY17 PAT (up 29% YoY) was 9% higher than...

21 Oct 2016 Axis Capital Limited 7 $69.00

Biocon | Q2FY17 Result Update | We expect financials to weaken over next few quarters hence maintain Sell rating with target of Rs 540.

Biocon | Q2FY17 Results Update We expect financials to weaken over next few quarters hence maintain Sell rating with target ...

21 Oct 2016 IndiaNivesh Securities Pvt Ltd 6 $58.00

Wright Investors Service Comprehensive Report for Biocon Limited

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

10 Oct 2016 Wright Reports 64 $75.00

Biocon Limited (BIOCON) - Financial and Strategic SWOT Analysis Review

Biocon Limited (BIOCON) - Financial and Strategic SWOT Analysis Review Summary Biocon Limited (Biocon) is a global biopharmac...

19 Sep 2016 GlobalData 100 $300.00